MERCK & CO. INC. (6MK.DE) Stock Overview
Europe - FRA:6MK - US58933Y1055 - Common Stock
6MK.DE Key Statistics, Chart & Performance
The current stock price of 6MK.DE is 76.3 EUR. In the past month the price increased by 12.37%. In the past year, price decreased by -21.42%.
6MK.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 50.04 | 658.74B | ||
| 1LLY.MI | ELI LILLY & CO | 50.07 | 659.21B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.99 | 448.18B | ||
| JNJ.DE | JOHNSON & JOHNSON | 18.61 | 400.65B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 18.48 | 397.91B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.91 | 257.18B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 14.17 | 244.39B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 15.54 | 226.49B | ||
| NOT.DE | NOVARTIS AG-REG | 15.11 | 220.26B | ||
| SNW.DE | SANOFI | 11.48 | 211.15B | ||
| 1SAN.MI | SANOFI | 11.48 | 211.27B | ||
| SAN.PA | SANOFI | 11.49 | 211.34B |
Related stock screener links
About 6MK.DE
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Company Info
MERCK & CO. INC.
126 East Lincoln Avenue, P.O. Box 2000
Rahway NEW JERSEY US
Employees: 75000
Phone: 19087404000
MERCK & CO. INC. / 6MK.DE FAQ
What is the stock price of MERCK & CO. INC. today?
The current stock price of 6MK.DE is 76.3 EUR. The price increased by 1.73% in the last trading session.
What is the ticker symbol for MERCK & CO. INC. stock?
The exchange symbol of MERCK & CO. INC. is 6MK and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is 6MK.DE stock listed?
6MK.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for MERCK & CO. INC. stock?
33 analysts have analysed 6MK.DE and the average price target is 86.17 EUR. This implies a price increase of 12.94% is expected in the next year compared to the current price of 76.3. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MERCK & CO. INC. worth?
MERCK & CO. INC. (6MK.DE) has a market capitalization of 190.58B EUR. This makes 6MK.DE a Large Cap stock.
How many employees does MERCK & CO. INC. have?
MERCK & CO. INC. (6MK.DE) currently has 75000 employees.
What are the support and resistance levels for MERCK & CO. INC. (6MK.DE) stock?
MERCK & CO. INC. (6MK.DE) has a support level at 73.99 and a resistance level at 76.6. Check the full technical report for a detailed analysis of 6MK.DE support and resistance levels.
Is MERCK & CO. INC. (6MK.DE) expected to grow?
The Revenue of MERCK & CO. INC. (6MK.DE) is expected to grow by 1.09% in the next year. Check the estimates tab for more information on the 6MK.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MERCK & CO. INC. (6MK.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 6MK.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 6MK.DE, evaluating the profitability, health, valuation and growth aspects
- MERCK & CO. INC. (6MK.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MERCK & CO. INC. (6MK.DE) Sales and EPS estimates to see what analysts future expectations are.
- MERCK & CO. INC. (6MK.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MERCK & CO. INC. (6MK.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- MERCK & CO. INC. (6MK.DE) Stock Chart to make your own analysis
- MERCK & CO. INC. (6MK.DE) Latest news and press-releases to stay up to date.
Does MERCK & CO. INC. (6MK.DE) stock pay dividends?
MERCK & CO. INC. (6MK.DE) has a dividend yield of 3.86%. The yearly dividend amount is currently 2.65. Check the full fundamental report for a detailed analysis of 6MK.DE dividend history, reliability and sustainability.
When does MERCK & CO. INC. (6MK.DE) report earnings?
MERCK & CO. INC. (6MK.DE) will report earnings on 2025-10-30, before the market open.
What is the Price/Earnings (PE) ratio of MERCK & CO. INC. (6MK.DE)?
The PE ratio for MERCK & CO. INC. (6MK.DE) is 11.51. This is based on the reported non-GAAP earnings per share of 6.63 and the current share price of 76.3 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 6MK.DE.
6MK.DE Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to 6MK.DE. When comparing the yearly performance of all stocks, 6MK.DE is a bad performer in the overall market: 86.6% of all stocks are doing better.
6MK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to 6MK.DE. 6MK.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
6MK.DE Financial Highlights
Over the last trailing twelve months 6MK.DE reported a non-GAAP Earnings per Share(EPS) of 6.63. The EPS increased by 18.28% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 25.79% | ||
| ROA | 13.96% | ||
| ROE | 33.49% | ||
| Debt/Equity | 0.69 |
6MK.DE Forecast & Estimates
33 analysts have analysed 6MK.DE and the average price target is 86.17 EUR. This implies a price increase of 12.94% is expected in the next year compared to the current price of 76.3.
For the next year, analysts expect an EPS growth of 17.93% and a revenue growth 1.09% for 6MK.DE